Hyperkinetic Movement Disorders E-Book
112,99 €
Mehr erfahren.
- Herausgeber: John Wiley & Sons
- Kategorie: Fachliteratur
- Sprache: Englisch
Hyperkinetic movement disorders comprise a range of diseases characterized by unwanted and uncontrollable, or poorly controllable, involuntary movements. The phenomenology of these disorders is quite variable encompassing chorea, tremor, dystonia, myoclonus, tics, other dyskinesias, jerks and shakes. Discerning the underlying condition can be very difficult given the range and variability of symptoms. But recognizing the phenomenology and understanding the pathophysiology are essential to ensure appropriate treatment.
Hyperkinetic Movement Disorders provides a clinical pathway for effective diagnosis and management of these disorders. The stellar international cast of authors distils the evidence so you can apply it into your practice. The judicious use of
- diagnostic criteria
- algorithms
- rating scales
- management guidelines
Provides a robust framework for clear patient management. Throughout the text, QR codes* provide smartphone access to case-study videos of hyperkinetic symptoms.
Purchase includes an enhanced Wiley Desktop Edition.* This is an interactive digital version featuring:
- all text and images in fully searchable form
- integrated videos of presentations
View a sample video: www.wiley.com/go/albanese - highlighting and note taking facilities
- book marking
- linking to additional references
Hyperkinetic Movement Disorders provides you with the essential visual and practical tools you need to effectively diagnose and treat your patients.
*Full instructions for using QR codes and for downloading your digital Wiley DeskTop Edition are inside the book.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 962
Veröffentlichungsjahr: 2012
Ähnliche
Contents
Preface
List of Contributors
List of Videos
PART 1: General Issues in Hyperkinetic Disorders
CHAPTER 1: Distinguishing Clinical Features of Hyperkinetic Disorders
Introduction
Historical background
Phenomenology and classification
Clinical examination and medical recording
CHAPTER 2: Pathophysiology and Molecular Pathology of Dystonia and Tics
Introduction
Dystonia
Gilles de la Tourette syndrome
CHAPTER 3: Pathophysiology and Molecular Pathology of Tremor, Myoclonus, and Chorea
Tremor
Tremor mechanisms
Various types of tremor
Myoclonus
Chorea
Epilogue
CHAPTER 4: Overview of the Medical Treatments of Hyperkinetic Disorders
Introduction
Motor phenotypes
Pathophysiology of hyperkinetic disorders
Medical treatments of hyperkinetic disorders
Summary
CHAPTER 5: Overview of Surgical Treatment Possibilities in Hyperkinetic Disorders
Introduction
Historical background
Phenomenology and clinical features
Physiology, pathophysiology, and neuropathology
Stereotactic central nervous system surgery
Surgical procedures
Peripheral nervous system surgery
Cortical stimulation
Transmagnetic cranial stimulation
Conclusions
PART 2: Tremor Syndromes
CHAPTER 6: Essential Tremor
Introduction
Historical background
Phenomenology and other clinical features
Epidemiology
Risk factors and etiology
Pathophysiology
Treatment
Conclusion
CHAPTER 7: Other Tremors
The definition, classification and diagnosis of tremor
Enhanced physiological tremors
Tremor in Parkinson’s disease
Cerebellar tremor syndromes
Dystonic tremor syndromes
Holmes tremor
Drug- and toxic-induced tremors
Orthostatic tremor
Palatal tremor
Task-specific tremors
Stroke-induced tremor
Tremor in systemic disorders
Post-traumatic tremor
Neuropathic tremor
PART 3: Dystonia Syndromes
CHAPTER 8: Primary Dystonias
Historical background
Classification
Epidemiology
Phenomenology of primary dystonia
Etiology
Pathophysiology
Treatment
CHAPTER 9: Secondary Dystonias
Historical background
Phenomenology and other clinical features
Neuroimaging features
Prevalence and etiology
Treatment
Conclusion
PART 4: Chorea Syndromes
CHAPTER 10: Huntington Disease and Other Genetic Choreas
Historical background
Phenomenology and other clinical features
Epidemiology
Etiopathogenesis
Neuropathology
Imaging
Treatment
Other genetic causes of chorea
Conclusion
CHAPTER 11: Acquired Choreas
Historical background
Phenomenology
Epidemiology
Etiology
Pathophysiology
Treatment
Conclusion
CHAPTER 12: Tics and Tourette Syndrome
Historical background
Phenomenology of tics and other clinical features of Tourette syndrome
Epidemiology
Etiology
Pathophysiology
Treatment
Conclusion
APPENDIX
CHAPTER 13: Secondary Tics
Introduction
Tics and infections
Tics and drugs
Tics and structural lesions
Tics and other neurodegenerative disorders
Miscellaneous
Management
PART 5: Myoclonus Syndromes
CHAPTER 14: Inherited Myoclonus Syndromes
Historical background
Phenomenology and other clinical features
Epidemiology
Etiology
Pathophysiology
Treatment
Other inherited myoclonus disorders
Conclusion
Acknowledgments
CHAPTER 15: Segmental Myoclonus
Introduction
Definition
Palatal myoclonus
Branchial myoclonus (excluding palatal)
Oculofacialmasticatory myorhythmia
Spinal segmental myoclonus
Diaphragmatic myoclonus
Abdominal/truncal myoclonus
Conclusion
CHAPTER 16: Other Jerks and Startles
Introduction
Myoclonias
Startle syndromes
Syndromes with peripheral injury
Miscellaneous other jerks and startles
PART 6: Ataxias
CHAPTER 17: Clinical and Pathophysiological Features of Cerebellar Dysfunction
Anatomical background
Physiology of the cerebellum
Clinical features of the cerebellar dysfunction and underlying mechanisms
Theories and computational models of cerebellar function
CHAPTER 18: Inherited and Sporadic Ataxias
Introduction
Autosomal Recessive Cerebellar Ataxias (ARCAs)
Autosomal dominant cerebellar ataxias (ADCAs)
X-Linked ataxias
Mitochondrial ataxias
Sporadic ataxias
PART 7: Other Hyperkinetic Disorders
CHAPTER 19: Dyskinesias in Parkinsonian Syndromes
Introduction
Parkinson disease
Phenomenology of dopaminergic drug-associated dyskinesias in PD
Epidemiology
Clinical impact
Rating scales
Pathophysiology
Treatment
Runaway dyskinesia after transplantation
Non-PD parkinsonian syndromes
Future perspectives
CHAPTER 20: Restless Legs Syndrome
Historical background
Clinical features
Epidemiology
Etiology
Pathophysiology
Treatment
Conclusions
CHAPTER 21: Tardive Dyskinesias
Historical background
Epidemiology
Phenomenology and other clinical features
Predisposing factors and clinical course of tardive dyskinesia
Etiology
Pathophysiology
Treatment
Metoclopramide
Conclusions
CHAPTER 22: Stereotypies and Other Developmental Hyperkinesias
Introduction
Stereotypies
Treatment
Prognosis
Other developmental hyperkinesias
Conclusions
CHAPTER 23: Paroxysmal Dyskinesias
Paroxysmal kinesigenic dyskinesia
Paroxysmal non-kinesigenic dyskinesia
Paroxysmal exercise-induced diskynesia
Other paroxysmal movement disorders
Other episodic disorders that can be confused with paroxysmal movement disorders
Conclusion
CHAPTER 24: Psychogenic Movement Disorders
Introduction
Diagnosis
Psychiatric classification
Clues suggesting the presence of a psychogenic movement disorder
General clinical features
Psychogenic tremor
Psychogenic dystonia
Psychogenic myoclonus
Psychogenic gait disorder
Psychogenic parkinsonism
Physiologic brain changes in psychogenic disorders
Treatment of psychogenic movement disorders
Plates
Index
This edition first published 2012, © 2012 by Blackwell Publishing Ltd
Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing program has been merged with Wiley’s global Scientific, Technical and Medical business to form Wiley-Blackwell.
Registered OfficeJohn Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial Offices9600 Garsington Road, Oxford, OX4 2DQ, UKThe Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK111 River Street, Hoboken, NJ 07030-5774, USA
For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell
The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.
Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought.
The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting a specific method, diagnosis, or treatment by physicians for any particular patient. The publisher and the author make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of fitness for a particular purpose. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. Readers should consult with a specialist where appropriate. The fact that an organization or Website is referred to in this work as a citation and/or a potential source of further information does not mean that the author or the publisher endorses the information the organization or Website may provide or recommendations it may make. Further, readers should be aware that Internet Websites listed in this work may have changed or disappeared between when this work was written and when it is read. No warranty may be created or extended by any promotional statements for this work. Neither the publisher nor the author shall be liable for any damages arising herefrom.
Library of Congress Cataloging-in-Publication Data
Hyperkinetic movement disorders : differential diagnosis and treatment / edited by Alberto Albanese, Joseph Jankovic.p. ; cm.Includes bibliographical references and index.
ISBN-13: 978-1-4443-3352-7 (hard cover : alk. paper)ISBN-10: 1-4443-3352-6 (hard cover : alk. paper)ISBN-13: 978-1-4443-4615-2 (ePDF)ISBN-13: 978-1-4443-4618-3 (Wiley Online Library)[etc.]1. Hyperkinesia. 2. Diagnosis, Differential. I. Albanese, Alberto. II. Jankovic, Joseph. [DNLM: 1. Hyperkinesis. 2. Movement Disorders. 3. Diagnosis, Differential. WL 390]RC376.5.H96 2012616.85′89–dc232011020595
A catalogue record for this book is available from the British Library.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books.
Preface
Hyperkinetic movement disorders have always puzzled neurologists and other clinicians because of uncertainties about their classification and treatment. At first sight, many hyperkinetic disorders may look alike, but a closer examination of their phenomenology, including pattern, rhythm, and anatomic distribution, usually allows for their proper categorization. Although in general neurology, clinical anatomical correlates are the cornerstone of diagnosis, in movement disorders phenomenology has an essential role. In our training and mentoring experience we enjoy the enthusiasm of young residents and fellows who begin to explore the many facets of hyperkinetic disorders. They soon recognize that proper phenomenological categorization is an essential element in the diagnosis of movement disorders, which then leads to finding the most likely etiology and treatment. Thus, as an example, if the clinician does not recognize patient’s chorea, the appropriate tests, such as Huntington disease DNA test, may not be ordered and the diagnosis may be delayed. Similarly, if one does not recognize a particular hyperkinesia as stereotypy, prior use of dopamine receptor blocking drugs may not be investigated and the diagnosis of tardive dyskinesia can be missed.
Until few years ago treatment options for hyperkinetic movement disorders were limited, but in recent years there has been a remarkable growth in effective and safe medical and surgical treatment strategies. Appropriate diagnosis, however, is critical before the most suitable disease-specific treatment is selected and offered to the patient.
Because of diagnostic challenges in the field of hyperkinetic movement disorders many patients seek multiple opinions. These consultations are sometimes done informally and facilitated by exchanging patient videos. Personal experience and expert knowledge are perhaps more important in this field than other neurological disciplines. Hence, the idea to assemble a unique volume dedicated to hyperkinetic movement disorders, accompanied by instructive videos, was the impetus for this book.
In planning this book we carefully selected true authorities in each field and, fortunately, they have accepted our invitation. As a result, we assembled the most outstanding, internationally renowned, faculty. We wish to thank the authors for their scholarly contributions. We also wish to thank the editorial and management staff of Wiley, particularly Michael Bevan, Julie Elliott, and Martin Sugden. Finally, we express our deep appreciation to our families, who allowed us to dedicate our time and effort to this project.
Alberto AlbaneseMilan, Italy
Joseph JankovicHouston, Texas
List of Contributors
Pratibha G. AiaDepartment of NeurologyEmory University School of MedicineAtlanta, GA, USAAlberto AlbaneseFondazione IRCCS IstitutoNeurologico Carlo BestaUniversità Cattolica del Sacro CuoreMilan, ItalyEmmanuelle ApartisService de PhysiologieHôpital Saint-AntoineParis, FranceTetsuo AshizawaDepartment of NeurologyUniversity of FloridaGainesville, FL, USAJulián Benito-LeónDepartment of Neurology, UniversityHospital “12 de Octubre,” andCentro de Investigación Biomédica en Red sobreEnfermedades Neurodegenerativas (CIBERNED)Madrid, SpainOscar BernalMovement Disorders Center & Department of NeurologyUniversity of FloridaGainesville, FL, USAKailash P. BhatiaSobell Department of MotorNeuroscience and Movement DisordersInstitute of Neurology,University College LondonLondon, UKFrancisco CardosoNeurology Service, Department of Internal MedicineThe Federal University of Minas GeraisBelo Horizonte, BrazilMiryam CarecchioSobell Department of MotorNeuroscience and Movement DisordersInstitute of NeurologyUniversity College LondonLondon, UKJohn Nathaniel CavinessDepartment of NeurologyMayo Clinic College of MedicineMayo Clinic ScottsdaleAZ, USALeslie CloudDepartment of NeurologyEmory University School of MedicineAtlanta, GA, USAAntonio E. EliaIstituto Neurologico Carlo Besta,Milan, ItalyStewart A. FactorDepartment of NeurologyEmory University School of MedicineAtlanta, GA, USAStanley FahnDepartment of NeurologyColumbia University College of Physicians SurgeonsNew York, NY, USAElisabeth M. FonckeDepartment of NeurologyFree University Medical Center (VUmc)Amsterdam, the NetherlandsChristopher G. GoetzThe Parkinson Disease and Movement Disorder CenterRush University Medical CenterChicago, IL, USADavid GrabliDepartment of NeurologySalpetrière HospitalPierre and Marie Curie UniversityParis, FranceGiuliana GrimaldiFonds National de la Recherche Scientifique (FNRS)Neurologie ULB-ErasmeBrussels, BelgiumAinhi HaParkinson’s Disease Center and Movement Disorders ClinicDepartment of NeurologyBaylor College of MedicineHouston, TX, USAMark HallettNational Institute of Neurological Disorders and StrokeBethesda, MD, USAPamela Hamilton-StubbsSleep Clinic for Children and AdultsRichmond, VA, USAJoseph JankovicParkinson’s Disease Center and Movement Disorders ClinicDepartment of Neurology, Baylor College of MedicineHouston, TX, USAElan D. LouisThe G.H. Sergievsky Center, Department of Neurology, and Taub Institute for Research on Alzheimer’s Disease and the Aging BrainCollege of Physicians and Surgeons and Department of EpidemiologyMailman School of Public HealthColumbia University, New YorkNY, USACodrin LunguNational Institute of Neurological Disorders and StrokeBethesda, MD, USAMario MantoFonds National de la Recherche Scientifique (FNRS)Neurologie ULB-ErasmeBrussels, BelgiumJoão MassanoSobell Department of MotorNeuroscience and Movement DisordersInstitute of NeurologyUniversity College LondonLondon, UKJonathan W. MinkDepartment of NeurologyDivision of Child NeurologyUniversity of RochesterMedical CenterRochester, NY, USARenato P. MunhozNeurology ServiceDepartment of Internal MedicineHospital de ClínicasFederal University of ParanáCuritiba, BrazilJudith Navarro-OtanoNeurology ServiceHospital Clinic de BarcelonaUniversity of BarcelonaBarcelona, SpainMichael S. OkunDepartments of Neurology & Neurological SurgeryMovement Disorders CenterUniversity of FloridaGainesville, FL, USAWilliam OndoDepartment of NeurologyBaylor College of MedicineHouston, TX, USAClaustre Pont-SunyerNeurology ServiceHospital Clinic de BarcelonaUniversity of BarcelonaBarcelona, SpainGonzalo J. RevueltaDepartment of NeurologyEmory University School of MedicineAtlanta, GA, USAEmmanuel RozeFédération des Maladies du Système NerveuxHôpital Pitié-SalpêtrièreParis, FranceSusanne A. SchneiderSchilling Section of Clinical and Molecular Neurogenetics at the Department of NeurologyUniversity LuebeckLuebeck, GermanyMichael SchupbachDepartment of NeurologySalpetrière HospitalPierre and Marie Curie UniversityParis, FranceJohannes D. SpeelmanDepartment of NeurologyAcademic Medical CenterUniversity of AmsterdamAmsterdam, the NetherlandsJayasri SrinivasanDepartment of NeurologyDivision of Child NeurologyUniversity of Rochester Medical CenterRochester, NY, USAHélio A.G. TeiveNeurology ServiceDepartment of Internal MedicineHospital de ClínicasFederal University of ParanáCuritiba, BrazilMarina A. TijssenDepartment of NeurologyAcademic Medical CenterUniversity of AmsterdamAmsterdam, the NetherlandsEduardo TolosaNeurology ServiceHospital Clinic de BarcelonaUniversity of BarcelonaBarcelona, SpainAnne-Fleur van RootselaarDepartment of NeurologyAcademic Medical CenterUniversity of AmsterdamAmsterdam, the NetherlandsVinata Vedam-MaiDepartment of Neurological SurgeryUniversity of FloridaGainesville, FL, USAMarie VidailhetDepartment of Neurology, ICM-CRICM Research CenterSalpetrière HospitalPierre and Marie Curie UniversityParis, FranceRuth H. WalkerDepartment of NeurologyJames J. Peters Veterans Affairs Medical Center, Bronx, NYand Mount Sinai School of MedicineNew York, NY, USAArthur S. WaltersDepartment of NeurologyVanderbilt University School of MedicineNashville, TN, USAS. Elizabeth ZauberDepartment of NeurologyIndiana University School MedicineIndianapolis, IN, USA
List of Videos
The videos in this book can be accessed either by scanning the QR (Quick Response) codes within this book using a QR reader app and the camera on your smart phone, or alternatively, copying the web link (listed under the QR code) into your web browser. QR code reader apps can be obtained from the app store market for your smartphone not from the publisher.
Video 6.1 Essential tremorVideo 7.1 Task-specific tremor (“handbag” tremor)Video 7.2 Dystonic head tremorVideo 7.3 Holmes tremorVideo 7.4 Drug-related tremor in a patient with segmental dystoniaVideo 8.1 Primary cervical dystoniaVideo 8.2 Primary dystonia: DYT1 phenotypeVideo 8.3 Primary dystonia: DYT6 phenotypeVideo 8.4 Primary dystonia: DYT13 phenotypeVideo 9.1 Hemidystonia following basal ganglia lesionVideo 9.2 Dystonia in PKANVideo 9.3 Complex regional pain syndromeVideo 9.4 Creutzfeldt–Jakob diseaseVideo 10.1 Mild generalized chorea in Huntington diseaseVideo 10.2 Moderate chorea in Huntington diseaseVideo 10.3 Chorea in Huntington diseaseVideo 10.4 Juvenile-onset Huntington diseaseVideo 10.5 Features associated with Huntington diseaseVideo 10.6 Progression of motor impairment in Huntington diseaseVideo 10.7 Chorea in ataxia telangectasiaVideo 10.8 Chorea in NeuroacanthocytosisVideo 11.1 Hemichorea due to vascular hypoperfusionVideo 11.2 Movement disorder of acquired hepatocerebral degenerationVideo 11.3 Celiac dyskinesiaVideo 12.1 Phenomenology of tics in Tourette syndromeVideo 12.2 Phenomenology of tics in Tourette syndromeVideo 12.3 Phenomenology of tics in Tourette syndromeVideo 12.4 Phenomenology of Tourette syndromeVideo 12.5 Phenomenology of Tourette syndromeVideo 12.6 Phenomenology of Tourette syndromeVideo 13.1 Tics following peripheral injuryVideo 14.1 Myoclonus-dystonia phenomenologyVideo 14.2 Myoclonus-dystonia phenomenologyVideo 14.3 Myoclonus-dystonia: lightning jerksVideo 14.4 Myoclonus-dystonia: deep brain stimulationVideo 14.5 Myoclonus in Unverricht–Lundborg diseaseVideo 14.6 Myoclonus in Lafora body diseaseVideo 15.1 Palatal myoclonusVideo 15.2 Segmental myoclonusVideo 15.3 Segmental myoclonusVideo 16.1 Focal myoclonusVideo 16.2 Generalized myoclonusVideo 16.3 Belly dancer’s dyskinesiaVideo 16.4 Painful legs and moving toesVideo 18.1 Ataxia phenomenologyVideo 18.2 Friedreich ataxiaVideo 18.3 SCA2 ataxiaVideo 18.4 SCA3 ataxiaVideo 19.1 Peak dose dyskinesiaVideo 19.2 Diphasic dyskinesiaVideo 19.3 Off dyskinesiaVideo 19.4 On-state dyskinesiaVideo 20.1 Periodic limb movements in sleepVideo 20.2 Restless leg syndromeVideo 21.1 Phenomenology of tardive dyskinesiasVideo 21.2 Phenomenology of tardive dyskinesiasVideo 21.3 Phenomenology of tardive dyskinesiasVideo 21.4 Phenomenology of tardive dyskinesias and response to treatmentVideo 22.1 Stereotypies in Rett syndromeVideo 22.2 Tardive stereotypiesVideo 22.3 Stereotypies in suspected taupathyVideo 23.1 Infantile paroxysmal kinesigenic dyskinesiaVideo 23.2 Paroxysmal kinesigenic dyskinesia while standingVideo 23.3 Autosomal dominant paroxysmal kinesigenic dyskinesiaVideo 23.4 Ballic paroxysmal kinesigenic dyskinesiaVideo 23.5 GLUT1 deficiencyVideo 23.6 Paroxysmal dyskinesia in patient with cerebral palsyVideo 24.1 Psychogenic tremorVideo 24.2 Psychogenic tremorVideo 24.3 Psychogenic dystoniaVideo 24.4 Psychogenic myoclonusVideo 24.5 Psychogenic gait disorderVideo 24.6 Psychogenic tic disorder
PART 1
General Issues in Hyperkinetic Disorders
CHAPTER 1
Distinguishing Clinical Features of Hyperkinetic Disorders
Alberto Albanese1and Joseph Jankovic2
1 Fondazione IRCCS Istituto Neurologico Carlo Besta, Università Cattolica del Sacro Cuore, Milan, Italy2 Parkinson’s Disease Center and Movement Disorders Clinic, Department of Neurology,Baylor College of Medicine, Houston, TX, USA
Introduction
Movement abnormalities can be dichotomized into the two broad categories of hypokinetic and hyperkinetic syndromes. The hallmark of hypokinesias is the loss of voluntary and automatic movements (akinesia), which is combined with slowness (bradykinesia) and stiffness or increased muscle tone (rigidity) in akinetic-rigid or parkinsonian syndromes [1]. In contrast, hyperkinesias are manifested by abnormal, uncontrollable, and unwanted movements. This term should not be confused with “hyperkinetic disorders” used in ICD 10 [2] to describe a behavioral abnormality – typically labeled attention deficit disorder with hyperactivity, occurring particularly in children and often associated with attention deficit and a tendency to move from one activity to another without completing any one. This is often associated with disorganized, ill-regulated, and scattered activity and thinking. This is not the only inconsistency between terminology in adult and childhood disorders, and efforts have been recently undertaken to unify the nosology and diagnostic recommendations in pediatric and adult movement disorders [3].
Hyperkinetic movement disorders include six main phenotypic categories, which can appear in isolation or in variable combinations: tremor, chorea, tics, myoclonus, dystonia, and stereotypies. In addition to these six categories there are other abnormalities of motor control that are also included within the field of movement disorders, such as akathisia, amputation stumps, ataxia, athetosis, ballism, hyperekplexia, mannerisms, myorhythmia, restlessness, and spasticity. The term “dyskinesia” is commonly used to indicate any or a combination of abnormal involuntary movements, such as tardive or paroxysmal dyskinesias or levodopa-induced dyskinesia, but more specific phenomenological categorization should be used whenever possible. In addition, there is a large and important group of peripherally-induced movement disorders, exemplified by hemifacial spasm [4], although any hyperkinetic movement disorder can be triggered or induced by peripheral injury [5].
Some conditions combine hypokinetic and hyperkinetic features, as exemplified by the coexistence of bradykinesia and tremor in Parkinson disease (PD) often referred to by the oxymora “gait disorder with acceleration” [6] or “shaking palsy” [7]. Probably the best examples of coexistent hyper- and hypokinesia is levodopa-induced dyskinesia in patients with PD and chorea or dystonia in patients with Huntington disease, many of whom have an underlying hypokinesia [8].
We describe here the hallmark features and phenomenology of the main hyperkinetic disorders, which are listed according to the time of their medical recognition.
Historical background
The importance of recognizing the appropriate phenomenology, not only as a guide to diagnosis but also as a means to study the pathophysiology of the disorder, is highlighted by the following statement attributed to Sir William Osler: “To study the phenomenon of disease without books is to sail an uncharted sea, while to study books without patients is not to go to sea at all” [9].
The characterization and classification of the various hyperkinetic disorders has evolved over a long period of time (Table 1.1). Tremor was a common language word before becoming a medical term. In ancient Greek, the root TRE is a lexical unit to indicate at the same time fear and shaking. Tremor was defined by Galen as an “involuntary alternating up and down motion of the limbs.” Involuntary movements present during action or at rest were also mentioned by Sylvius [10]. Parkinsonian tremor was later described by James Parkinson [7] and further differentiated from kinetic “intentional tremor” by Charcot [11]. The familial occurrence of postural action tremor was recognized shortly afterwards [12].
Epidemics of “dancing mania” emerged in central Europe in the late Middle Ages as local phenomena [13] or in connection with pilgrimages. Coincident with the Black Plague in 1348–50, St Vitus was called upon to intercede, leading to the term “chorea Sancti Viti” (St Vitus dance) to indicate at the same time a request for intercession and a means to expiate. This terminology has entered medical literature after Paracelcus described this syndrome among one of the five that “deprive man of health and reason.” He adopted the term “chorea” into medical jargon and proposed using the expression “chorea lasciva” to describe the epidemics [14]. One century later, Thomas Sydenham observed an epidemic affecting only children which he called “chorea minor” [15] and was later recognized to be a manifestation of rheumatic fever. Adult-onset hereditary chorea was described in the 19th century [16] and later renamed Huntington chorea.
Table 1.1 Chronology of first description of the main hyperkinetic disorders.
Date
Name
First usage
Ancient Greece
Tremor
τρεμω (to tremble, to fear)
XI Century
Chorea
Choreomania (ritual dance)
XVII Century
Tic
French horse breeders
1871
Athetosis
Hammond [71]
1881
Myoclonus
Friedreich [21]
1885
Ballism
Kussmaul [72]
1911
Dystonia
Oppenheim [24]
1953
Asterixis
Adams [23]
The term “tic” arose in France in the 17th century to describe shivers in horses, particularly of certain breeds, which affect primarily the muscles of the pelvic region, pelvic limbs, and tail [17]. The word was later used by French doctors by analogy. The first medical report on human tics is probably the description of the Marquise of Dampierre, who started having tics at 7 years of age [18]. Later, Trousseau listed tics among choreatic disorders [19] and Gilles de la Tourette provided a separate taxonomic categorization of these phenomena [20].
Essential myoclonus was first described by Friedrich [21], who reported a 50-year-old man with a 5-year history of multifocal muscle jerks affecting both sides of the body symmetrically, but asynchronously. The syndrome was defined as “paramyoclonus multiplex” because of the reported symmetry. Forms of myoclonic epilepsy were later described and Lundborg [22] proposed a classification of myoclonus that remains largely in use today. Asterixis was observed in patients with hepatic encephalopathy [23] and later recognized to be a form of negative myoclonus.
Dystonia was the last main hyperkinetic disorder to be recognized: its name derives from a supposed alteration of muscle tone in patients with generalized distribution [24]. The hereditary nature was noted at about the same time [25].
Table 1.2 Tremor types can be differentiated based on frequency, amplitude and onset in relation to voluntary movements.
Phenomenology and classification
Although at first sight involuntary movements resemble each other, each hyperkinetic disorder has a specific phenomenology (signature) that can be identified by direct observation of the patient or videotaped examination. Duration, rhythmicity, topography, and other features must be carefully analyzed and noted in order to make a specific phenomenological diagnosis [26] (Table 1.2).
Tremor
Tremor is an involuntary, rhythmic, oscillation of a body region about a joint axis. It is usually produced by alternating or synchronous contractions of reciprocally innervated agonistic and antagonistic muscles that generate a relatively symmetric velocity in both directions about a midpoint of the movement [27, 28]. The oscillation produced by tremor can be represented by a sinusoidal curve; it is generated by rhythmical discharges in an oscillating neuronal network and maintained by feedback and feed-forward loops. The resulting movement is patterned and rhythmic, characteristics that distinguish tremor from other hyperkinesias [29].
Tremor varies when different voluntary movements are performed or postures are held: it is labeled as a rest tremor, postural tremor, or action tremor according to the condition of greatest severity. Intention tremor, typically associated with cerebellar dysfunction, is characterized by the worsening of tremor on approach to a target, as in a finger-to-nose maneuver. The typical rest tremor of PD has a frequency of 4 to 6 Hz, and is most prominent distally. Its characteristic appearance in the hand is also referred to as a pill-rolling tremor. Parkinsonian rest tremor also typically involves the chin, jaw, and legs, but almost never involves the neck. Indeed, head oscillation should suggest essential tremor or dystonic tremor rather than PD. True rest tremor, however, disappears during complete rest, such as sleep, and is reduced or disappears with voluntary muscle contraction, or during movement. Postural tremor is present with the maintenance of a particular posture, such as holding the arms outstretched in front of the body. It is commonly seen in physiological and essential tremor. Re-emergent tremor refers to a postural tremor that occurs after a variable latency period during which time no observable postural tremor is present [30]. This typically occurs in the setting of PD, and most likely represents a parkinsonian rest tremor that has been “reset” during the maintenance of a posture [31].
Task-specific tremor occurs only during execution of a particular task, such as writing, and is considered by many to be a variant of dystonic tremor. Dystonic tremor may occur in the setting of dystonia, and is a rhythmic, oscillation-like, dystonic movement [32]. Position-specific tremors only occur when the affected body part is placed in a particular position or posture. Orthostatic tremor is an example of a position-specific tremor, and refers to a fast (14–16 Hz) tremor, mainly affecting the trunk and legs, that occurs after standing for a certain period of time [33].
Chorea
Chorea is an irregular, unpredictable, involuntary random-appearing sequence of one or more, discrete, involuntary jerk-like movements or movement fragments. Movements appear random due to the variability in timing, duration, direction, or anatomic location. Each movement may have a distinct start and end point, although these may be difficult to identify since movements are often strung together, one immediately following or overlapping another. Movements may, therefore, appear to flow randomly from one muscle group to another, and can involve trunk, neck, face, tongue, and extremities. Infrequent and mild chorea may appear as isolated, small-amplitude brief movements. It may resemble restless, fidgety, or anxious behavior. When chorea is more severe, it may appear to be almost continuous, flowing from one site of the body to another (Figure 1.1).
Although chorea may be worsened by movement, it usually does not stop with attempted relaxation. Chorea is distinguished from tremor and dystonia by its lack of rhythmicity and predictability. Chorea may be difficult to differentiate from myoclonus, but the latter is more intermittent rather than continuous. Chorea is typically a fluent disorder involving contiguous body parts in variable order and direction. It may be associated with hypotonia, hung-up and pendular reflexes, and motor impersistence (inability to maintain a sustained contraction). Examples of impersistence include an inability to maintain prolonged tongue protrusion or handgrip (“milkmaid grip”). The term “parakinesia” refers to the incorporation of the involuntary movements into semipurposeful movements, in a semiconscious attempt to camouflage the chorea. Examples of parakinesia include touching one’s face, adjusting glasses, and other mannerisms that often served to delay the recognition of the involuntary movement.
Ballism is characterized by high amplitude, almost violent, movements that mainly involve the proximal limb joints. It is considered an extreme phenomenological expression of the spectrum of chorea that affects proximal joints such as shoulder or hip. This leads to large amplitude movements of the limbs, sometimes with a flinging or flailing quality. As patients recover from acute ballism, frequently associated with a stroke in the contralateral subthalamic nucleus, the ballistic movements often gradually evolve into chorea or dystonia (see Chapters 10 and 11).
Tics
Tics are repeated, individually recognizable, intermittent movements or movement fragments that are almost always briefly suppressible and are usually associated with the awareness of an urge to perform the movement, the so-called “premonitory sensation.” Motor tics often result in either a simple jerk-like movement such as a blink, facial grimace, head jerk, or shoulder shrug, or more complex, stereotyped, semivoluntary, intermittent movements. Tics are usually abrupt in onset, fast and brief (clonic tics), slow and sustained (dystonic tics), or manifested by sudden cessation of movement because of isometric muscle contractions (tonic tics), or inhibition of voluntary movement (blocking tics). The duration of each tic movement is characteristic of that tic, and the duration does not generally vary between different repetitions [34]. Tics can occur during all stages of sleep.
Characteristic features include predictability of both the nature of the movement and its onset, suggestibility, exacerbation during excitement or stress and also after stress (rebound), and brief voluntary suppressibility. Complex motor tics may resemble normal motor acts or gestures, but are generally inappropriately intense and timed [34]. The movements can appear purposeful, such as touching, throwing, hitting, jumping, and kicking, or non-purposeful, such as head shaking or trunk bending. Occasionally tics can be so severe as to cause neurological sequels, with reports of compressive cervical myelopathy resulting from recurrent head thrusting and violent neck hyperextension tics [35]. Complex motor tics can also include copropraxia (grabbing or exposing one’s genitals) or echopraxia (imitating gestures).
Figure 1.1 This photographic sequence (1.5 frames per second) permits an appreciation of the rapid flow of chorea motor fragments in a patient with Huntington disease.
Motor tics are almost invariably accompanied by vocal or phonic tics and many experts view motor and phonic tics are having the same pathophyiological mechanism. Simple phonic tics can involve brief occurrences of sniffing, throat clearing, grunting, screaming, coughing, blowing, or sucking sounds. Pathological laughter has also been reported as a manifestation of a simple phonic tic [36]. In contrast, complex phonic tics are semantically meaningful utterances and include coprolalia, or shouting of obscenities, profanities, or other insults. Other complex phonic tics include echolalia (repeating someone else’s words or phrases) and palilalia (repeating one’s own utterances, particularly the last syllable, word, or phrase in a sentence). Rarely, tics may be continuous and disabling, resulting in a so-called “tic status” [37] or in severe, self-injurious, even life-threatening behaviors, so called “malignant Tourette syndrome” [38]. Because of the broad expression of Tourette syndrome, manifested not only by motor and phonic tics but by a variety of behavioral comorbidities (such as attention deficit with hyperactivity, obsessive-compulsive disorder, and impulsivity), the management depends on establishing an appropriate hierarchy of the various symptoms and targeting the therapeutic strategies to the most troublesome problems [39]. (See Chapters 12 and 13).
Athetosis
Athetosis is a slow, continuous, involuntary writhing movement that (1) prevents the maintenance of a stable posture; (2) involves continuous smooth movements that appear to be random and are not composed of recognizable movement fragments; (3) typically involves the distal extremities (hands or feet) more than the proximal and can also involve the face, neck, and trunk; and (4) may worsen with attempts at movement or posture, but can also occur at rest.
Athetosis rarely occurs in isolation but is much more commonly associated with chorea and dystonia. In fact, it is considered a variant of distal chorea or dystonia. Phenomenologically, athetosis is at the opposite end of ballism, resulting in a slow, gentle, and distal motion, resembling slow chorea. The recognition of athetosis often leads to consideration of cerebral palsy or paroxysmal choreoathetosis. Pseudoathetosis refers to a severe distal sensory loss syndrome whereby involuntary, slow, writhing movements are due to loss of proprioception [40].
Myoclonus
Myoclonus consists of repeated, often non-rhythmic, brief shock-like jerks due to the sudden involuntary contraction or relaxation of one or more muscles. These “lightning-like” movements differ from epileptic myoclonus and do not affect consciousness [41]. Myoclonus may be synchronous (several muscles contracting simultaneously), spreading (several muscles contracting in a predictable sequence), or asynchronous (several muscles contracting with varying and unpredictable relative timing). When myoclonus affects more than one muscle in an apparently random and varying pattern it is called multifocal; it is called generalized when many muscles through the body are involved simultaneously. Myoclonus is characterized by a sudden unidirectional movement due to agonist contraction (positive myoclonus) or by sudden brief muscle relaxation (negative myoclonus) [42]. The latter is exemplified by asterixis, which typically presents in patients with hepatic and other encephalopathy.
The distinction between myoclonus and other involuntary disorders – particularly tics, chorea, and different varieties of jerks – is not always clear. Tics are usually associated with a generalized, conscious, urge or local premonitory sensation to move and a feeling of relief of tension after the movement. In addition, many tics are suppressible, in contrast to myoclonus. Brief muscle movements in dystonia are often associated with dystonic posturing. Mild chorea may be difficult to distinguish from myoclonus. Sometimes myoclonus is rhythmic and can resemble tremor. When myoclonus is repeated rhythmically it is also called “myoclonic tremor”, but this is a misnomer as rhythmical myoclonus, such as palatal myoclonus [43], is caused by contractions of agonists only, not alternating contractions of antagonist muscles as seen in tremor.
Myoclonus can be caused or worsened by movement and can sometimes occur during sleep. Myoclonus can be categorized as action myoclonus, postural myoclonus, or rest myoclonus on the basis of the condition in which it is observed [44]. It can also be categorized on the basis of the presumed anatomic origin as cortical, subcortical, brainstem, propriospinal, or spinal. Myoclonus may coexist with dystonia (as in myoclonus-dystonia syndrome) or with tremor (as in essential myoclonus) [45]. (See Chapters 14, 15, and 16).
Dystonia
In dystonia, involuntary sustained or intermittent muscle contractions cause twisting and repetitive movements, abnormal postures, or both. The combination of postures and dystonic movements is typical of dystonia [46].
Dystonic postures are repeated and particular patterns or postures are characteristic of each patient at a given point in time. Similar dystonic postures may occur in different patients. Postures can be sustained, particularly at the peak of dystonic movements, or may occur during very brief intervals. Dystonic postures are often triggered by attempts at voluntary movement or voluntary posture, and in some cases they are triggered only in particular body positions or by particular movements as may occur in task-specific dystonia. With the exception of certain seizure disorders [47], dystonic movements or postures are not typically seen during sleep, possibly due to inhibition of movements by spinal mechanisms [48]. Postures tend to occur at intervals determined by voluntary movement and can be sustained for variable lengths of time. Relaxation may be impaired so that the dystonic posture may be maintained well beyond the end of the attempted voluntary movement that triggered it. There may be multiple dystonic postures in the same patient, so that different dystonic postures may be combined.
Dystonic movements may vary in terms of speed, amplitude, rhythmicity, forcefulness, and distribution in the body, but the same muscles are usually involved; hence the term “patterned” movement disorder. Dystonia may occur at rest, during activity or only during a specific motor movement or posture, so-called task- or position-specific dystonia (Figure 1.2) [49]. The most common adult-onset upper limb task-specific dystonia is writer’s cramp [50]. Musician’s cramp occurs while playing a musical instrument [51]. Embouchure dystonia affects the control of the lip, jaw, and tongue muscles, and may be seen in woodwind and brass players [52].
Figure 1.2 Increasing severity of dystonia is often associated with loss of task-specificity and relation to voluntary movement.
The term “fixed dystonia” is used to indicate persistent, abnormal posture, without a dynamic component. When present but untreated for weeks or longer, dystonia may lead to fixed contractures. Fixed dystonia is often associated with painful contracture, as in post-traumatic, chronic regional pain syndrome [53] or sustained voluntary contraction as in psychogenic dystonia. (see Chapter 24).
Dystonia is typically associated with the occurrence of gestes antagonistes (or sensory tricks), mirror phenomena and overflow [54–56]. Their recognition supports the clinical diagnosis of dystonia [46]. Dystonia can affect any body part, with a wide range in severity from very mild to extremely severe cases (see Chapters 8 and 9).
Stereotypies
Stereotypies are involuntary or unvoluntary (in response to or induced by inner sensory stimulus or unwanted feeling), coordinated, patterned, repetitive, rhythmic, seemingly purposeless movements or utterances [57]. Although stereotypies typically occur in children with autism or other pervasive developmental disorders, they can also occur in adults. Typical motor stereotypies encountered in children with autism include body rocking, head nodding, head banging, hand washing and waving, covering ears, fluttering of fingers or hands in front of the face, repetitive and sequential finger movements, eye deviations, lip smacking, and chewing movements, pacing, object fixation, and skin picking. Phonic stereotypies include grunting, moaning, and humming. In adults, stereotypies are usually encountered in patients with tardive dyskinesias. In this setting stereotypies are usually in the form of orofacial or lingual chewing movements, pelvic rocking movements and other repetitive coordinated movements. They are often accompanied by akathisia, manifested by motor and sensory restlessness (see Chapters 21 and 22).
Non-motor features
Psychiatric morbidity is higher in patients with hyperkinetic movement disorders than in community samples or in patients with other forms of chronic disease. Behavioral abnormalities have been reported in patients with Tourette syndrome [58], Wilson disease [59], dystonia [60], essential tremor [61], Sydenham chorea [62] and Huntington disease gene carriers [63]. Age at onset is likely to be an important determinant of susceptibility to psychiatric morbidity in many of these conditions.
Given the complexity of basal ganglia functions, it is not surprising that hyperkinetic disorders are frequently associated with behavioral or psychological changes that, in many cases, are considered to have a pathogenic commonality with the motor disturbance. Basal ganglia pathology engenders a wide spectrum of neuropsychiatric symptoms [64], which are thought to involve the associative circuit (focused on the dorsolateral caudate nucleus and the caudoventral putamen) and the emotional circuits (centered in the ventral caudate nucleus, the nucleus accumbens, and the amygdala) [65, 66].
Particularly chorea, tics, and dystonia are coincident with obsessive-compulsive traits, anxiety, or depression in different combinations and with variable severity. Such coincidence may be due to an underlying basal ganglia dysfunction producing both motoric and behavioral expressivity. Of particular interest is the finding that depression, attention-deficit hyperactivity disorder and vocal tics are significantly more common in children with Sydenham chorea, compared to children who had rheumatic fever without Sydenham chorea [67]. Medication-related adverse effects may be an additional source of depression or anxiety in patients with hyperkinetic movement disorders and cause akathisia or additional hyperkinesias [68–70].
Behavioural features associated with hyperkinetic disorders should not be confounded with psychogenic movement disorders, which are abnormal movements thought to be due to pre-existing psychological or psychiatric disturbances. The borderland between movement disorders and psychiatry is a difficult diagnostic area. It is remarkable that most movement disorders were initially considered psychogenic due to the inexplicability of their phenomenology, such as the paradigmatic case of primary dystonia, featuring bizarre postural abnormalities, relief by gestes antagonistes, task specificity, and normal brain morphology. The organic nature of primary hyperkinetic movement disorder is now unequivocally recognized, although they may not always be easily differentiated from psychogenic hyperkinesias. Chronicity, social impairment, and stigma, however, can affect the ability of patients with hyperkinetic disorders to develop or continue many of their key social roles, such as marital or employment status, thus engendering reactive depression or other secondary behavioral consequences.
Clinical examination and medical recording
Although the expert clinician can quickly attempt to recognize the features of hyperkinetic disorders (Figure 1.3) it is necessary to accomplish a thorough documentation of the observed features to avoid mistakes and allow review and comparison of the phenotype [26, 57].
Examination of patients with a hyperkinetic movement disorder must include a full examination for associated neurological findings. It must also include an assessment of the effect of the movement disorder on overall motor function and quality of life. Observation of the disorder itself should include several components, including the phenomenology of the disorder, the time-course, triggers and suppressibility, and the somatic distribution (focal, segmental, multifocal, and generalized). The phenomenology should be described in terms of duration, speed, amplitude, jerkiness, repeatability, or stereotyped quality, and the number of different identifiable movements or postures. The time-course should be described in terms of rhythmicity, whether it is intermittent with intervening more normal movement, whether movements are sustained or ongoing, and whether there are discrete submovements or movement fragments or whether the movement appears to be continuously flowing. Possible triggers should be assessed from the history and examination, including attempted movement, posture, rest, and emotional state. Suppressibility can be tested in clinic or assessed from the history, and the presence of an urge to move should be determined. Distractibility evaluates whether unrelated mental or physical tasks (as opposed to asking the patient to voluntarily suppress) result in movement suppression. Distractibility can be seen in tics, stereotypies, and psychogenic movements.
Figure 1.3 Flow chart for a quick orientation in the differential diagnosis of the five main hyperkinetic disorders.
Table 1.3 General features of hyperkinetic disorders.
Given the patient’s consent, it is valuable to take a video of the clinical interview and medical examination. This allows the examiner to review the phenomenology of the hyperkinetic disorder, to seek expert consultation and visually compare phenomenology changes during natural course of the condition. It is particularly important to show as clearly as possible on the video clip the features listed in Tables 1.3 and 1.4, allowing the specifics of the observed phenomena to be visually evaluated. A well-constructed video recording can convey more accurate information than standard clinical notes.
Table 1.4 Distinctive features of hyperkinetic disorders.
References
1 Zaidel A, Arkadir D, Israel Z, Bergman H. Akineto-rigid vs. tremor syndromes in Parkinsonism. Curr Opin Neurol 2009; 22:387–93.
2 World Health Oranization. International Statistical Classification of Diseases and Related Health Problems. Tenth revision 2nd edition. Geneva: World Health Organization 2007.
3 Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, et al. Definition and classification of hyperkinetic movements in childhood. Mov Disord 2010; 15(25):1538–49.
4 Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord 2011; 26:1582–92.
5 Jankovic J. Peripherally induced movement disorders. Neurol Clin 2009; 27:821–32.
6 Boissier de Sauvages F. Nosologia methodica sistens morborum classes juxtà Sydenhami mentem & botanicorum ordinem. Amsterdam: De Tournes 1768.
7 Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones 1817.
8 Del Sorbo F, Albanese A. Levodopa-induced dyskinesias and their management. J Neurol 2008; 255(Suppl 4):32–41.
9 Bean WB. Sir William Osler Aphorisms. New York: Henry Schuman, Inc 1950.
10 de la Boë F. Disputationes medicarum pars prima, primarias corporis humani functiones naturales en anatomicis, practicis et chymicis experimentiis deductas complectens. Amsterdam: van den Bergh 1663.
11 Charcot JM. Leçons sur les maladies du système nerveux. Paris: A. Delahaye 1872.
12 Dana CL. Hereditary tremor: a hitherto undescribed form of motor neurosis. Am J Med Sci 1887; 94:386–93.
13 Waller J. A forgotten plague: making sense of dancing mania. Lancet 2009; 21(373):624–5.
14 von Hohenheim P. Von den Krankheiten, so die Vernunfft berauben. Basel: Adam of Bodenstein. 1567.
15 Sydenham T. Schedula monitoria de novae febris ingressu. London: G. Kettilby. 1686.
16 Huntington G. On chorea. Medical and Surgical Reporter (Philadelphia) 1872; 26:317–21.
17 DeLahunta A, Glass E. Veterinary neuroanatomy and clinical neurology 3rd ed. St. Louis: Saunders Elsevier. 2008.
18 Itard JMG. Mémoire sur quelques fonctions involontaires des appareils de la locomotion, de la préhension et de la voix. Archives Générales de Médecine 1825; 8:385–407.
19 Trousseau A. Clinique médicale de l’Hôtel-Dieu de Paris 5 edn. Paris: J.-B. Baillière 1877.
20 Gilles de la Tourette GE. La maladie des tics convulsifs. La Semaine Médicale 1899; 19:153–6.
21 Friedreich N. Neuropathologische Beobachtung beim Paramyoklonus multiplex. Virchows Arch Path Anat 1881; 86:421–9.
22 Lundborg H. Die progressive Myoklonus-Epilepsie (Unverricht’s Myoklonie). Upsala: Almqvist & Wiksell 1903.
23 Adams RD, Foley JM. The neurological disorders associated with liver disease. Res Publ Assoc Res Nerv Ment Dis 1953; 32:198–237.
24 Oppenheim H. Über eine eigenartige Krampfkrankheit des kindlichen und jugendlichen Alters (Dysbasia lordotica progressiva, Dystonia musculorum deformans). Neurolog Centralb 1911; 30:1090–7.
25 Flatau E, Sterling W. Progressiver Torsionspasm bie Kindern. Z ges Neurol Psychiat 1911; 7:586–612.
26 Jankovic J, Lang AE. Movement disorders: diagnosis and assessment. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, editors. Neurology in clinical practice, 5th edn. Philadelphia, PA: Butterworth-Heinemann (Elsevier) 2008; pp 293–325.
27 Hallett M. Classification and treatment of tremor. JAMA 1991; 28(266):1115–17.
28 Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998; 13(Suppl 3): 2–23.
29 Jankovic J, Fahn S. Physiologic and pathologic tremors. Diagnosis, mechanism, and management. Ann Intern Med 1980; 93:460–5.
30 Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson’s disease. J Neurol Neurosurg Psychiat 1999; 67:646–50.
31 Fekete R, Jankovic J. Revisiting the relationship between essential tremor and Parkinson’s disease. Mov Disord 2011; 26:391–8.
32 Lalli S, Albanese A. The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov Disord 2010; 15:1619–26.
33 Piboolnurak P, Yu QP, Pullman SL. Clinical and neurophysiologic spectrum of orthostatic tremor: case series of 26 subjects. Mov Disord 2005; 20:1455–61.
34 Jankovic J. Tourette syndrome. Phenomenology and classification of tics. Neurol Clin 1997; 15:267–75.
35 Krauss JK, Jankovic J. Severe motor tics causing cervical myelopathy in Tourette’s syndrome. Mov Disord 1996; 11:563–6.
36 Cavanna AE, Ali F, Leckman JF, Robertson MM. Pathological laughter in Gilles de la Tourette syndrome: an unusual phonic tic. Mov Disord 2010; 15(25):2233–9.
37 Kovacs N, Herold R, Janszky J, Komoly S, Nagy F. Tics status: a movement disorder emergency: observations. J Neurol 2011; 258:143–5.
38 Cheung MY, Shahed J, Jankovic J. Malignant Tourette syndrome. Mov Disord 2007; 15:1743–50.
39 Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord 2011; 26:1149–56.
40 Spitz M, Costa Machado AA, Carvalho Rdo C, Maia FM, Haddad MS, Calegaro D, et al. Pseudoathetosis: report of three patients. Mov Disord 2006; 21:1520–2.
41 Halliday AM. The electrophysiological study of myoclonus in man. Brain 1967; 90:241–84.
42 Shibasaki H, Hallett M. Electrophysiological studies of myoclonus. Muscle Nerve 2005; 31:157–74.
43 Deuschl G, Wilms H. Clinical spectrum and physiology of palatal tremor. Mov Disord 2002; 17(Suppl 2), S63–S66.
44 Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet Neurol 2004; 3:598–607.
45 Dijk JM, Tijssen MA. Management of patients with myoclonus: available therapies and the need for an evidence-based approach. Lancet Neurol 2010; 9:1028–36.
46 Albanese A, Lalli S. Is this dystonia? Mov Disord 2009; 24:1725–31.
47 Meierkord H, Fish DR, Smith SJ, Scott CA, Shorvon SD, Marsden CD. Is nocturnal paroxysmal dystonia a form of frontal lobe epilepsy? Mov Disord 1992; 7:38–42.
48 Fish DR, Sawyers D, Smith SJ, Allen PJ, Murray NM, Marsden CD. Motor inhibition from the brainstem is normal in torsion dystonia during REM sleep. J Neurol Neurosurg Psychiat 1991; 54:140–4.
49 Fahn S. Concept and classification of dystonia. Adv Neurol 1988; 50:1–8.
50 Pont-Sunyer C, Marti MJ, Tolosa E. Focal limb dystonia. Eur J Neurol 2010; 17(Suppl 1):22–7.
51 Jankovic J, Ashoori A. Movement disorders in musicians. Mov Disord 2008; 30(23):1957–65.
52 Frucht SJ, Fahn S, Greene PE, O’Brien C, Gelb M, Truong DD, et al. The natural history of embouchure dystonia. Mov Disord 2001; 16:899–906.
53 Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain 2004; 127:2360–72.
54 Albanese A. The clinical expression of primary dystonia. J Neurol 2003; 250:1145–51.
55 Sitburana O, Jankovic J. Focal hand dystonia, mirror dystonia and motor overflow. J Neurol Sci 2008; 15(266):31–3.
56 Sitburana O, Wu LJ, Sheffield JK, Davidson A, Jankovic J. Motor overflow and mirror dystonia. Parkinsonism Relat Disord 2009; 15:758–61.
57 Fahn S, Jankovic J, Hallett M. Principles and practice of movement disorders. Philadelphia, PA: Churchill Livingstone Elsevier 2011.
58 Gaze C, Kepley HO, Walkup JT. Co-occurring psychiatric disorders in children and adolescents with Tourette syndrome. J Child Neurol 2006; 21:657–64.
59 Brewer GJ. Behavioral abnormalities in Wilson’s disease. Adv Neurol 2005; 96:262–74.
60 Jahanshahi M. Behavioral and psychiatric manifestations in dystonia. Adv Neurol 2005; 96:291–319.
61 Louis ED. Behavioral symptoms associated with essential tremor. Adv Neurol 2005; 96:284–90.
62 Maia DP, Teixeira AL, Jr., Quintao Cunningham MC, Cardoso F. Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea. Neurology 2005; 24:1799–801.
63 van Duijn E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiat Clin Neurosci 2007; 19:441–8.
64 Saint-Cyr JA, Taylor AE, Nicholson K. Behavior and the basal ganglia. Adv Neurol 1995; 65:1–28.
65 de Olmos JS, Heimer L. The concepts of the ventral striatopallidal system and extended amygdala. Ann N Y Acad Sci 1999; 29(877):1–32.
66 Garcia-Cairasco N, Miguel EC, Rauch SL, Leckman JF. Current controversies and future directions in basal ganglia research. Integrating basic neuroscience and clinical investigation. Psychiatr Clin North Am 1997; 20:945–62.
67 Marques-Dias MJ, Mercadante MT, Tucker D, Lombroso P. Sydenham’s chorea. Psychiat Clin North Am 1997; 20:809–20.
68 Kane JM, Fleischhacker WW, Hansen L, Perlis R, Pikalov A, III, Assuncao-Talbott S. Akathisia: an updated review focusing on second-generation antipsychotics. J Clin Psychiat 2009; 70:627–43.
69 Sinclair LI, Christmas DM, Hood SD, Potokar JP, Robertson A, Isaac A, et al. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiat 2009; 194:483–90.
70 Madhusoodanan S, Alexeenko L, Sanders R, Brenner R. Extrapyramidal symptoms associated with antidepressants–a review of the literature and an analysis of spontaneous reports. Ann Clin Psychiat 2010; 22:148–56.
71 Hammond WA. A treatise of diseases of the nervous system. New York: Appleton Century Crofts 1871.
72 Kussmaul A. Ziemssen’s Handbuch der Speciellen Pathologie und Therapie. Leipzig: Vogel 1885.
CHAPTER 2
Pathophysiology and Molecular Pathology of Dystonia and Tics
Marie Vidailhet, Michael Schupbach, and David Grabli
Department of Neurology, ICM-CRICM Research Center, Salpetrière Hospital and Pierre and Marie Curie University, Paris, France
Introduction
In this chapter we focus on dystonia and tics as they may share similarities in the pathophysiology:they can be considered as models of: dysfunction of the basal ganglia-cortical pathways; the sensorimotor loop for dystonia; and the motor, associative, and limbic loops for tics and Gilles de la Tourette syndrome.
Dystonia
Dystonia is defined as involuntary, sustained and often repetitive, muscle contractions of opposite muscles that lead to abnormal movements or posture. This definition, although commonly accepted, does not reflect the complexity and variety of syndromes enclosed within the denomination of dystonia. Here, we attempt to update the implication of genetic forms in the pathophysiology of dystonia, explore the animal models, and summarize recent advances in neuroimaging and neurophysiology.
Molecular pathology
Up to 20 genetic forms of dystonia have been identified to date [1]. The phenotype of these forms is presented in Chapter 7. Although the gap between molecular pathology and dystonic phenotype is far from being bridged, identification of the functions of the mutated genes has been possible for some primary dystonia forms providing new insight into the pathophysiological processes underlying the expression of these different clinical patterns (Table 2.1). Interestingly, several recent works have highlighted functional links between the proteins encoded by these genes.
DYT1 dystonia is related to mutations in the TOR1A gene. Torsin A, an AAA+ ATPase, is a protein whose exact cellular function is not yet known. This protein may play a role in cellular membranes (nuclear envelope and endoplasmic reticulum) homeostasis and may be involved in proteins processing/trafficking and excretory pathways. Other potential functions include synaptic vesicles recycling, neurite outgrow and postnatal maturation events involving neurons (especially at the synaptic level) [2] and glia [3].
DYT3 dystonia is caused by complex changes in TAF1/DYT3 transcripts. TAF1/DYT3 comprises at least 43 exons that are alternatively spliced. Alternative splicing of exon 1–38 encodes isoform of TATA box binding protein-associated factor I (TAF1]. Exons d1–d5 located downstream to exon 38 can either form separate transcripts regulated by separate promoters [4]. or transcripts spliced to some of exons 1–37 of TAF1 [5]. It is not clear how these changes in TAF1/DYT3 transcript system cause the disease but several lines of evidence point to modifications of D2 receptors expression or disruption of various gene expression in the striatum [1].
Table 2.1 DYT coding for dystonia genes and locus.
DYT6 dystonia is caused by mutations in the gene that encodes THAP (thanatos- associated protein) domain-containing apoptosis-associated protein 1 (THAP1] [6, 7]. In addition to the identified mutations, a rare non-coding substitution in THAP1 might increase the risk of dystonia [6]. The THAP1 protein is a sequence-specific DNA-binding factor which regulates cell proliferation and plays roles in cell survival and/or apoptosis. [8]. Recently, THAP1 was found to bind two proteins: HCF–1 protein, a potent transcriptional coactivator and cell cycle regulator, and OGT protein, a O-linked N-acetylglucosamine (O-GlcNAc) transferase, an enzyme which plays an role in a whole host of cellular processes as transcriptional regulation, signaling, proteasomal degradation and organelle trafficking [9].
DYT11 dystonia is related to mutations in the SGCE gene. They result in the synthesis of either aberrant e-sarcoglycan molecules or none at all, and are “loss of function” [10]. The spectrum of myoclonus dystonia-DYT11 associated with mutations within the SGCE gene [11] has been expanded to microdeletion [12] and Silver–Russel syndrome (uniparental disomy of chromosome 7).
Outline of a dystonia molecular network
Links between DYT1 and DYT6
Recent evidence suggests that THAP1 is able to interact with the promoter of DYT1/TOR1A and that THAP1 mutations causing dystonia alter this interaction. However, it was not possible to prove in blood cells or fibroblast lines that DYT1 expression was reduced in THAP1-mutated patients or increased by THAP1 overexpression. This direct interaction may thus only occur in specific region of the brain or at key developmental steps [13].
Links between DYT6 and DYT3
THAP1 shares sequence characteristics, in vivo expression patterns and protein partners with THAP3 [9]. Transcriptional dysregulation leading to increased neuronal vulnerability, may contribute to diseases such as DYT6 and DYT3 (X-linked dystonia-parkinsonism) caused by reduced expression of RNA polymerase II TATA box-binding protein-associated factor 1 (TAF1). In these two diseases, THAP1 (DYT6) and TAF1 (DYT3) are crucial to cell-cycle progression in dividing cells and mutations in either protein is likely to favor cell-cycle arrest and probably cell death [14]. In addition, THAP3 interacts with HCF–1 through a consensus HCF–1-binding motif (HBM), a motif that is also present in THAP1 and the gene encoding the THAP1/DYT6 protein partner OGT maps within the DYT3 critical region on Xq13.1 [9]. A link may also exist between DYT1 and DYT6.
Dopamine dysfunction: a link between DYT1, DYT11
A beneficial effect of levodopa has been observed in some myoclonus-dystonia patients [15]. The SCGE gene is also strongly expressed in dopaminergic neurons. Dysregulation of dopamine release has been observed in animal models and reduced dopamine D2 receptor availability was found in patients. The role of dopamine dysfunction in DYT1 dystonia has been emphasized [16–18]: dopamine transporter activity is reduced in DYT1 animal models, with altered dynamics of reuptake and release of dopamine [19]. In addition, reduced striatal D2 receptor binding was found in DYT11 [20]. Finally, TAF1, implicated in Lubag (DYT3 dystonia) may also play a role in the regulation of the DRD2 gene, and a decreased expression of the DRD2 gene has been found. Together, these results suggest that alteration in the dopamine signaling pathway may be crucial in various forms of dystonia.
Animal models
Several animal models have been developed throughout the years, although none of them can perfectly mimic the complexity of the clinical features observed in humans. These various models basically display dysfunctions within the main motor networks.
Cortex–basal ganglia loops
Various types of dystonia, from abnormal postures to phasic movements or myoclonic dystonia [21], have been produced after microinjections of bicuculline (antagonist of GABA-A receptors) into the posterior putamen, corresponding to the sensorimotor territory [22] and the sensorimotor territory of the external globus pallidus (GPe) [23]. Injections within the thalamus [ventral lateralis, nucleus pars oralis (VLo) and ventral anterior nucleus (VA)] induced contralateral dystonic postures, whereas injections in the caudal part [ventral posterolateral nucleus, pars oralis (VPLo) and ventralis lateralis nucleus, pars caudalis (VLc] induced myoclonic dystonia. This suggested that dystonia might result from a dysfunction of the motor pallidal relay (rostral) but also points to the cerebellar relay (caudal) of the thalamus [21]. Impairment of synaptic plasticity in the striatum is a critical point and has been demonstrated in DYT1 mice models. Abnormal plasticity in the cortex-basal ganglia loop is underlined by aberrant long-term potentiation (LTP) and depression (LTD) phenomena [24, 25] with an unbalanced cholinergic transmission. Systemic 3-NP increased NMDA receptor-dependent LTP at the level of the corticostriatal synapses [26]. At the cortical level, in the SMA proper, there is also an increase in excitability and loss of selectivity [21]. Lesions and pharmacological manipulations of the brainstem (e.g. interstitial nucleus of Cajal, pedunculopontine nucleus, and red nucleus that receives input from the basal ganglia and the cerebellum) may elicit dystonic movements [27].
Cerebellum–basal ganglia-cortex
Based on two animal models with dystonic movements originating from cerebellar dysfunctions, the role of the cerebellum in the pathophysiology of dystonia has been emphasized [28]. Additional subclinical lesions of the striatum exaggerated the dystonic attacks [29]. Moreover, in normal mice, when dystonic movements were triggered by a local application of kainic acid on the cerebellar cortex, microdialysis revealed a reduction in striatal dopamine release [29] Taken together, these various results in mice support the hypothesis that dystonia may arise from the dysfunction of a motor network involving the basal ganglia, the cerebellum, the cortex, and the dopaminergic system. Apart from the interaction at the cortical level, a disynaptic pathway linking an output stage of cerebellar processing (dentate nucleus) with an input stage of basal ganglia processing (striatum) was recently demonstrated [30]. Cortical areas (the SMA and the pre-SMA) are also the targets of disynaptic projections from the dentate nucleus of the cerebellum and from the GPi [31, 32].
Sensorimotor disruption
Environmental factors
Some arguments support the fact that there is a link between stereotyped, skilled repetitive movements and the vulnerability to develop task-specific dystonia. In a large case-control study [33], the risk of being affected by writer’s cramp increased progressively with the time spent writing each day and was also associated with an abrupt increase in the writing time during the year before onset, but this finding must be interpreted cautiously because of the strong possibility of a retrospective recall bias.
